Literature DB >> 2798330

RBEs of thermal neutron capture therapy and 10B(n, alpha)7 Li reaction on melanoma-bearing hamsters.

J Hiratsuka1, M Kono, Y Mishima.   

Abstract

Using Greene's melanoma transplanted into Syrian (golden) hamsters, we determined the relative biological effectiveness (RBE) of thermal neutron capture therapy (TNCT) using 10B-paraboronophenylalanine (10B-BPA) in comparison with a 9-MeV electron beam. We also obtained the RBE of the 10B(n, alpha)7 Li reaction by calculation based on summed dose data from TNCT. Throughout this study, the Kyoto University Research Reactor was used as the source for thermal neutrons; the reactor was specially altered to attain a low contamination level both for gamma-rays and fast neutrons. 10B-BPA was administered 8 hours before thermal neutron irradiation to the hamsters with melanoma. The tumor was then irradiated at 5 MW for 90 minutes. The absorbed dose from this TNCT was calculated by the method of Fairchild and Goodman (Phys. Med. Biol. 1966; 2:15-30). The RBEs of the TNCT and the 10B(n, alpha)7 Li reaction obtained by the tumor growth delay time (TGDT) method were 2.22 and 2.51, respectively, at 10.5 days of TGDT. These RBE values varied with TGDT and the absorbed dose. The RBE value of TNCT had a peak at 7.0 days of TGDT; that of the 10B(n, alpha)7Li reaction was higher at a low absorbed dose level and lower at a high absorbed dose level.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2798330     DOI: 10.1111/j.1600-0749.1989.tb00219.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  4 in total

1.  Biodistribution of boron concentration on melanoma-bearing hamsters after administration of p-, m-, o-boronophenylalanine.

Authors:  J Hiratsuka; K Yoshino; H Kondoh; Y Imajo; Y Mishima
Journal:  Jpn J Cancer Res       Date:  2000-04

Review 2.  Boron Neutron Capture Therapy (BNCT) for Cutaneous Malignant Melanoma Using 10B-p-Boronophenylalanine (BPA) with Special Reference to the Radiobiological Basis and Clinical Results.

Authors:  Hiroshi Fukuda
Journal:  Cells       Date:  2021-10-26       Impact factor: 6.600

Review 3.  Response of Normal Tissues to Boron Neutron Capture Therapy (BNCT) with 10B-Borocaptate Sodium (BSH) and 10B-Paraboronophenylalanine (BPA).

Authors:  Hiroshi Fukuda
Journal:  Cells       Date:  2021-10-26       Impact factor: 6.600

4.  Long-term outcome of cutaneous melanoma patients treated with boron neutron capture therapy (BNCT).

Authors:  Junichi Hiratsuka; Nobuhiko Kamitani; Ryo Tanaka; Ryoji Tokiya; Eisaku Yoden; Yosinori Sakurai; Minoru Suzuki
Journal:  J Radiat Res       Date:  2020-11-16       Impact factor: 2.724

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.